“Exploiting a loophole in the federal 340B drug program—a program intended to benefit the needy—[pharmaceutical companies] have in recent years begun imposing their will on Mississippi medical providers and pharmacies,” the defendant contended.
AstraZeneca Sues an Attorney General as Big Pharma Challenges Rise
Leave a Reply